Clinical Trial

IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This clinical trial investigates the safety, feasibility, and therapeutic potential of a combined approach using HiCM-188 cardiomyocyte injection delivered intramyocardially alongside either LVAD implantation or CABG surgery in patients with advanced ischemic heart failure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-04.
Trial Details
NCT Number NCT06866600
Lead Sponsor HELP Therapeutics Co., Ltd.
Conditions Heart Failure, Heart Failure At NYHA Stage III or IV
Enrollment 40 participants
Start Date 2025-03
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-14